# Credits - US Medication Risk Evaluation and Mitigation Strategies (REMS) FHIR IG v2.0.0

* [**Table of Contents**](toc.md)
* **Credits**

## Credits

This Implementation Guide is the result of the efforts of the CodeX REMS Integration Use Case, with the support and active participation of the following participants:

* AbbVie
* APCER
* Bristol Meyers Squibb
* InfoWerks
* Invaryant
* Lamics
* MITRE
* NCPDP
* Otsuka
* Point-of-Care Partners
* Prescryptive
* REMS Industry Consortium (RIC)
* Syneos
* UBC
* US Food and Drug Administration (FDA)

Our thanks to these organizations and to the individuals not explicitly listed who contributed their time, enthusiasm and expertise to this work.

